Anti-tribbles pseudokinase 2 (TRIB2)-immunization modulates hypocretin/ orexin neuronal functions

Sleep

Volumn 40, Issue 1, 2017, Pages

  Tanaka, Susumu ^a,b   Honda, Yoshiko ^a   Honda, Makoto ^a   Yamada, Hisao ^b   Honda, Kazuki ^a   Kodama, Tohru ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Ataxin 3; Hypocretin; Narcolepsy; Orexin; TRIB2

Indexed keywords

ATAXIN 3; ENZYME ANTIBODY; MESSENGER RNA; OREXIN; OREXIN A; TRIBBLES PSEUDOKINASE 2 ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; NEUROPEPTIDE; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELL COUNT; CELL DESTRUCTION; CELL FUNCTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; HYPOTHALAMIC TISSUE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NARCOLEPSY; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; RAT; ANIMAL; HYPOTHALAMUS; IMMUNOLOGY; METABOLISM; MOUSE; SPRAGUE DAWLEY RAT; TRANSGENIC ANIMAL; TRANSGENIC MOUSE; VACCINATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ATAXIN-3; AUTOANTIBODIES; AUTOANTIGENS; BIOMARKERS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; FEMALE; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, TRANSGENIC; NARCOLEPSY; NEURONS; NEUROPEPTIDES; OREXINS; RATS; RATS, SPRAGUE-DAWLEY; VACCINATION;

EID: 85014243194     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/zsw036     Document Type: Article

References (49)

1. American Academy of Sleep Medicine. International Classification of SLEEP DISORDERS, 2nd ed. Westchester, IL: Diagnostic & Coding Manual; 2005.
2. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000; 355(9197): 39-40.
3. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens. 1984; 24(5): 316-319.
4. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 2001; 68(3): 686-699.
5. Hor H, Kutalik Z, Dauvilliers Y, et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet. 2010; 42(9): 786-789.
6. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet. 2009; 41(6): 708-711.
7. Kornum BR, Kawashima M, Faraco J, et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet. 2011; 43(1): 66-71.
8. Dauvilliers Y, Abril B, Mas E, Michel F, Tafti M. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology. 2009; 73(16): 1333-1334.
9. Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol. 2004; 56(6): 905-908.
10. Faraco J, Lin L, Kornum BR, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 2013; 9(2): e1003270.
11. Cvetkovic-Lopes V, Bayer L, Dorsaz S, et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest. 2010; 120(3): 713-719.
12. Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep. 2010; 33(7): 875-878.
13. Kawashima M, Lin L, Tanaka S, et al. Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep. 2010; 33(7): 869-874.
14. Lim AS, Scammell TE. The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy? Sleep. 2010; 33(7): 857-858.
15. Katzav A, Arango MT, Kivity S, et al. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. J Autoimmun. 2013; 45: 24-30.
16. Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 2001; 30(2): 345-354.
17. Terao A, Wisor JP, Peyron C, et al. Gene expression in the rat brain during sleep deprivation and recovery sleep: an Affymetrix GeneChip study. Neuroscience. 2006; 137(2): 593-605.
18. Chen CT, Dun SL, Kwok EH, Dun NJ, Chang JK. Orexin A-like immunoreactivity in the rat brain. Neurosci Lett. 1999; 260(3): 161-164.
19. Archelos JJ, Hartung HP. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci. 2000; 23(7): 317-327.
20. Honda M, Arai T, Fukazawa M, et al. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy. Neurology. 2009; 73(7): 511-517.
21. Chen W, Black J, Call P, Mignot E. Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis. Ann Neurol. 2005; 58(3): 489-490.
22. Waleh NS, Apte-Deshpande A, Terao A, Ding J, Kilduff TS. Modulation of the promoter region of prepro-hypocretin by alpha-interferon. Gene. 2001; 262(1-2): 123-128.
23. Lecendreux M, Libri V, Jaussent I, et al. Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination? J. Autoimmun. 2015; 60: 20-31.
24. Grossberg AJ, Zhu X, Leinninger GM, et al. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci. 2011; 31(31): 11376-11386.
25. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007; 8(3): 171-181.
26. Harris GC, Aston-Jones G. Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res. 2007; 176(2): 251-258.
27. Gulia KK, Mallick HN, Kumar VM. Orexin A (hypocretin-1) application at the medial preoptic area potentiates male sexual behavior in rats. Neuroscience. 2003; 116(4): 921-923.
28. Gross PM, Blasberg RG, Fenstermacher JD, Patlak CS. The microcirculation of rat circumventricular organs and pituitary gland. Brain Res Bull. 1987; 18(1): 73-85.
29. Peruzzo B, Pastor FE, Blazquez JL, et al. A second look at the barriers of the medial basal hypothalamus. Exp Brain Res. 2000; 132(1): 10-26.
30. Deli MA, Descamps L, Dehouck MP, et al. Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res. 1995; 41(6): 717-726.
31. Fiala M, Looney DJ, Stins M, et al. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med. 1997; 3(8): 553-564.
32. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003; 348(26): 2646-2655.
33. Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT. Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol. 2009; 9(6): 449-456.
34. Tanaka S, Kuratsune H, Hidaka Y, et al. Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med. 2003; 12(2): 225-230.
35. Yamamoto S, Ouchi Y, Nakatsuka D, et al. Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor. PLoS One. 2012; 7(2): e51515.
36. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000; 6(9): 991-997.
37. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000; 27(3): 469-474.
38. Lein ES, Hawrylycz MJ, Ao N, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2007; 445(7124): 168-176.
39. Tanaka S, Takizawa N, Honda Y, et al. Hypocretin/orexin loss changes the hypothalamic immune response. Brain Behav Immun. 2016; 57: 58-67.
40. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007; 85(5): 1185-1196.
41. Sergeyev V, Broberger C, Hokfelt T. Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Brain Res Mol Brain Res. 2001; 90(2): 93-100.
42. Okun ML, Giese S, Lin L, Einen M, Mignot E, Coussons-Read ME. Exploring the cytokine and endocrine involvement in narcolepsy. Brain Behav Immun. 2004; 18(4): 326-332.
43. Tanaka S, Honda M, Toyoda H, Kodama T. Increased plasma IL-6, IL-8, TNF-alpha, and G-CSF in Japanese narcolepsy. Hum Immunol. 2014; 75(8): 940-944.
44. Del Rey A, Randolf A, Pitossi F, Rogausch H, Besedovsky HO. Not all peripheral immune stimuli that activate the HPA axis induce proinflammatory cytokine gene expression in the hypothalamus. Ann N Y Acad Sci. 2000; 917: 169-174.
45. Del Rey A, Randolf A, Wildmann J, Besedovsky HO, Jessop DS. Re-exposure to endotoxin induces differential cytokine gene expression in the rat hypothalamus and spleen. Brain Behav Immun. 2009; 23(6): 776-783.
46. Hakansson M, de Lecea L, Sutcliffe JG, Yanagisawa M, Meister B. Leptin receptor-and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. J Neuroendocrinol. 1999; 11(8): 653-663.
47. Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002; 3(9): 651-662.
48. Li QL, Jansen E, Friedman TC. Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines. Mol Cell Endocrinol. 1999; 158(1-2): 143-152.
49. Shatz CJ. MHC class I: an unexpected role in neuronal plasticity. Neuron. 2009; 64(1): 40-45.